Biotransformation of letrozole in rat liver microsomes: Effects of gender and tamoxifen
- 1 February 2007
- journal article
- Published by Elsevier in Journal of Pharmaceutical and Biomedical Analysis
- Vol. 43 (3) , 1078-1085
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- Aromatase inhibitors for breast cancer: lessons from the laboratoryNature Reviews Cancer, 2003
- Aromatase Inhibitors in Breast Cancer: An UpdateCancer Control, 2002
- Risks and Benefits of Aromatase Inhibitors in Postmenopausal Breast CancerDrug Safety, 1999
- Tamoxifen for Prevention of Breast Cancer: Report of the National Surgical Adjuvant Breast and Bowel Project P-1 StudyJNCI: Journal of the National Cancer Institute, 1998
- Tamoxifen for early breast cancer: an overview of the randomised trialsThe Lancet, 1998
- Recent advances in endocrine therapy of breast cancerBMJ, 1997
- Effect of tamoxifen on bone mineral density measured by dual-energy x-ray absorptiometry in healthy premenopausal and postmenopausal women.Journal of Clinical Oncology, 1996
- Tamoxifen: Toxicities and Drug Resistance During the Treatment and Prevention of Breast CancerAnnual Review of Pharmacology and Toxicology, 1995
- Effect of tamoxifen on lumbar spine bone mineral density in postmenopausal women after 5 yearsArchives of internal medicine (1960), 1994
- Effects of 4-hydroxytamoxifen and a novel pure antioestrogen (ICI 182780) on the clonogenic growth of human breast cancer cells in vitroBritish Journal of Cancer, 1994